Can Flow Cytometry Immunophenotyping Predict Cytogenetic Abnormalities in Acute Myeloid Leukemia? A Focus on Myelodysplasia‐Related Cytogenetic Abnormalities
This study identifies markers that distinguish AML-MRC, including CD235a, CD41a, and CD34. This suggests that acute erythroid leukemia and acute megakaryocytic leukemia are subsets within the AML-MRC category. Additionally, the study validates previously reported immunophenotypic characteristics of AML with t(8;21) and inv(16).
Authors
- Theera Ruchutrakool (ORCID: https://orcid.org/0000-0001-5717-515X)
- Orathai Promsuwicha
- Weerapat Owattanapanich (ORCID: https://orcid.org/0000-0002-1262-2005)
- Smith Kungwankiattichai (ORCID: https://orcid.org/0000-0001-6072-4025)
- Supattra Kankhaw
Institutions
- Siriraj Hospital (TH)
- Mahidol University (TH)
Publication Details
- Journal
- International Journal of Laboratory Hematology
- Published
- 2025-08-26
- DOI
- https://doi.org/10.1111/ijlh.14546
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00